Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | No observations |
| List | Section | Observation |
|---|---|---|
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: X 60 CAPSULAS |
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 06.03. FARMACOS QUE AFECTAN EL METABOLISMO DE LOS LIPIDOS | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 12.6 Hypolipidemiants | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 13. Antianémicos e hipolipemiantes | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | C. APARELHO CARDIOVASCULAR | No observations |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 10. AGENTES QUE REDUCEN LOS LÍPIDOS SÉRICOS | No observations |
| Belize. National Drug Formulary | 12.06 Lipid-lowering agents | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.12 Lipid-Regulating Drugs | No observations |
| List | Section | Observation |
|---|---|---|
| Chile. Formulario Nacional de Medicamentos. 2005 | 11.06. HIPOLIPEMIANTES | No observations |
| Guyana. Essential Medicines List. 2020-2021 | Reserved for specialist use | No observations |
| Belize. National Drug Formulary | 12.06 Lipid-lowering agents | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | C. APARELHO CARDIOVASCULAR | No observations |